Patents are the ‘go-to’ form of Intellectual Property (IP) protection for new pharmaceuticals. Through patents, protection can be attained for…
Read MoreSMEs
Filter By
Digital technology, pharmaceutical and green transport patent applications increase as the EPO’s latest figures confirm European patent applications return to growth
The European Patent Office’s latest patent index shows that patent applications filed at the EPO hit a record number in…
Read MoreThe ‘Next Normal’: why SMEs will be the first responders
The global business community is experiencing the biggest challenge since the Second World War: the COVID-19 pandemic. In a six…
Read MoreOwning it: why SMEs must invest in trade mark protection
Understanding the business drivers SMEs face and addressing their concerns is fundamental to us as Intellectual Property (IP) professionals. And…
Read MoreMaking money from innovation
When developing a new product, it can take years before it is a self-sustaining enterprise. This is a problem for…
Read MoreIntellectual Property: the lifeblood of SMEs
Much has been written about why a startup company should invest in Intellectual Property (IP), or why it is vital…
Read MoreSteps we’re taking for our Barker Brettell community
We would like to wish all of our clients and contacts our best wishes as the COVID-19 situation develops and…
Read MoreTop five cosmetic trends shaping IP in 2020
If you’re operating in the cosmetics sector, being in touch with the latest developments – whether they are technological innovations…
Read MoreBarker Brettell primed to ease clients through the Brexit transition period
On the 31 January 2020, the UK and EU ratified the UK’s Withdrawal Agreement from the EU, meaning that the…
Read More